Literature DB >> 28336607

Genome Sequence of Human Rhinovirus A22, Strain Lancaster/2015.

Kate V Atkinson1, Lisa A Bishop1,2, Glenn Rhodes3, Nicolas Salez4, Neil R McEwan5, Matthew J Hegarty5, Julie Robey6, Nicola Harding6, Simon Wetherell6, Robert M Lauder1, Roger W Pickup1,3, Mark Wilkinson2, Derek Gatherer7.   

Abstract

The genome of human rhinovirus A22 (HRV-A22) was assembled by deep sequencing RNA samples from nasopharyngeal swabs. The assembled genome is 8.7% divergent from the HRV-A22 reference strain over its full length, and it is only the second full-length genome sequence for HRV-A22. The new strain is designated strain HRV-A22/Lancaster/2015.
Copyright © 2017 Atkinson et al.

Entities:  

Year:  2017        PMID: 28336607      PMCID: PMC5364232          DOI: 10.1128/genomeA.01713-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Human rhinovirus A (order Picornavirales; family Picornaviridae; genus Enterovirus; species rhinovirus A) presents a diverse cluster of genotypes (1) and has been implicated in opportunistic infections in immunocompromised patients (2), community-acquired pneumonia of infants (3), chronic respiratory infection in cystic fibrosis (4), and exacerbation of asthma and chronic obstructive pulmonary disease (COPD) (5). It has a positive-sense single-stranded RNA genome of 7.1 kb, encoding a polyprotein that is processed into 11 mature peptides. Rhinovirus A genotype 22 (HRV-A22) has one complete genome sequence in GenBank, that of the ATCC VR-1132 reference strain (accession no. FJ445122). Eleven other fragments have been deposited, ranging in size from 207 to 1,713 bases. Six volunteers with COPD were recruited from a general practice surgery in Lancaster, United Kingdom (54.05°N, 2.80°W). RNA was obtained from nasopharyngeal swabs taken between 5 January 2015 and 25 February 2015. One patient was asymptomatic at time of sampling, and the other five patients exhibited symptoms consistent with respiratory tract infection. Ethical approval was granted by the UK National Research Ethics Service, reference 14/LO/1634, NIHR Clinical Research Network (UKCRN) Portfolio, ID 17799. All methods were carried out in accordance with the relevant guidelines and regulations. Pooled RNA underwent deep sequencing using an Illumina Nextera XT library and HiSeq 2500 system (SRA accession no. SRR4733497), and an HRV-A22 genome was assembled using Bowtie 1.1.1 (6) and BWA 0.7.12-r1039 (7), with FJ445122 as the template. The assembled genome is 7,129 bases in length and differs from the reference genome at 620 positions (8.7%), with four gaps. Eleven bases in a run starting at position 2129 could not be resolved. The polyprotein, excluding the unresolved 11 bases, differs from the reference polyprotein at 34 positions (1.6%). The new strain is only the second full-length genome of HRV-A22 and has been designated HRV-A22/Lancaster/2015. Three pediatric patients with cough and other respiratory symptoms were consented to give nasal swabs between 17 December 2014 and 6 February 2015, which were similarly processed (SRA accession no. SRR4733499). Their deep-sequence reads produced partial alignments to HRV-A22/Lancaster/2015 without mismatches. Deep sequencing of seven pooled sets of RNA (SRA accession no. SRP092324) from a further 139 volunteers (of which 63 had respiratory symptoms) yielded no reads aligning to HRV-A22/Lancaster/2015. Finding HRV-A22 in pediatric and COPD deep-sequencing pools only is consistent with the clinical literature on rhinovirus A (3, 5). McIntyre et al. (8) recommend that a divergence of 10.5% in the VP1 gene should be used as the threshold for designation of a new genotype of human rhinovirus A. We aligned 870 bases of HRV-A22/Lancaster/2015 in VP1 with homologous sequences from HRV-A22 strains KM4 (accession no. KF015733), Ledford et al. (9) (accession no. AY355203), Laine et al. (10) (accession no. AY450473), and ATCC VR-1132 (accession no. FJ445122). Phylogenetic analysis shows that HRV-A22/Lancaster/2015 is a nearest neighbor of strain KM4, (Kunming, China, 2011), at 3.0% divergence, and is 9.7% divergent from the other HRV-A22 strains, in VP1. Lancaster/2015 and KM4 thus represent an outlier group within HRV-A22 but are insufficiently divergent to constitute a novel genotype (BAM files, alignments, and phylogenetic trees are available from https://doi.org/10.17635/lancaster/researchdata/123).

Accession number(s).

The genome sequence of HRV-A22/Lancaster/2015 has been deposited in GenBank under the accession number KY342346.
  10 in total

1.  Phylogenetic analysis of human rhinovirus capsid protein VP1 and 2A protease coding sequences confirms shared genus-like relationships with human enteroviruses.

Authors:  Pia Laine; Carita Savolainen; Soile Blomqvist; Tapani Hovi
Journal:  J Gen Virol       Date:  2005-03       Impact factor: 3.891

2.  Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution.

Authors:  Ann C Palmenberg; David Spiro; Ryan Kuzmickas; Shiliang Wang; Appolinaire Djikeng; Jennifer A Rathe; Claire M Fraser-Liggett; Stephen B Liggett
Journal:  Science       Date:  2009-02-12       Impact factor: 47.728

3.  Respiratory viruses in HIV-infected patients with suspected respiratory opportunistic infection.

Authors:  Jorge Garbino; Sarra Inoubli; Erik Mossdorf; Rainer Weber; Michael Tamm; Paola Soccal; John-David Aubert; Pierre-Olivier Bridevaux; Caroline Tapparel; Laurent Kaiser
Journal:  AIDS       Date:  2008-03-30       Impact factor: 4.177

4.  Chronic rhinovirus infection in an adult with cystic fibrosis.

Authors:  William G Flight; Rowland J Bright-Thomas; Peter Tilston; Kenneth J Mutton; Malcolm Guiver; A Kevin Webb; Andrew M Jones
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

5.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.

Authors:  Ben Langmead; Cole Trapnell; Mihai Pop; Steven L Salzberg
Journal:  Genome Biol       Date:  2009-03-04       Impact factor: 13.583

6.  VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds.

Authors:  Rebecca M Ledford; Nitesh R Patel; Tina M Demenczuk; Adiba Watanyar; Torsten Herbertz; Marc S Collett; Daniel C Pevear
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

7.  Human rhinovirus C infections mirror those of human rhinovirus A in children with community-acquired pneumonia.

Authors:  Zichun Xiang; Richard Gonzalez; Zhengde Xie; Yan Xiao; Jun Liu; Lan Chen; Chunyan Liu; Jing Zhang; Lili Ren; Guy Vernet; Gláucia Paranhos-Baccalà; Kunling Shen; Qi Jin; Jianwei Wang
Journal:  J Clin Virol       Date:  2010-08-21       Impact factor: 3.168

8.  Fast and accurate long-read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2010-01-15       Impact factor: 6.937

9.  Proposals for the classification of human rhinovirus species A, B and C into genotypically assigned types.

Authors:  Chloe L McIntyre; Nick J Knowles; Peter Simmonds
Journal:  J Gen Virol       Date:  2013-05-15       Impact factor: 3.891

10.  Viral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmission.

Authors:  Peter A B Wark; Melinda Tooze; Heather Powell; Kristy Parsons
Journal:  Respirology       Date:  2013-08       Impact factor: 6.424

  10 in total
  1 in total

1.  Nasopharyngeal metagenomic deep sequencing data, Lancaster, UK, 2014-2015.

Authors:  Kate V Atkinson; Lisa A Bishop; Glenn Rhodes; Nicolas Salez; Neil R McEwan; Matthew J Hegarty; Julie Robey; Nicola Harding; Simon Wetherell; Robert M Lauder; Roger W Pickup; Mark Wilkinson; Derek Gatherer
Journal:  Sci Data       Date:  2017-10-24       Impact factor: 6.444

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.